Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12

Cancer Research

Volumn 59, Issue 16, 1999, Pages 4035-4041

  Nishioka, Yasuhiko ^a   Hirao, Motohiro ^a   Robbins, Paul D ^a   Lotze, Michael T ^a   Tahara, Hideaki ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b 300 Kaufmann Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE THERAPY; GENETIC TRANSDUCTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0033566984     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
2. Lamont, A. G., and Adorini, L. IL-12: a key cytokine in immune regulation. Immunol. Today, 17: 214-217, 1996.
3. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87: 581-586, 1995.
4. Sgadari, C., Angiolillo, A. L., and Tosato, G. Inhibition of angiogenesis by interleukin 12 is mediated by the interferon-inducible protein 10. Blood, 87: 3877-3882, 1996.
5. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
6. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. T. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol., 153: 1697-1706, 1994.
7. Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, H. J., III, McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., and Lotze, M. T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 154: 6466-6474, 1995.
8. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., and Colombo, M. P. CD4 T cells inhibit in vivo the CDS-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 gene. Eur. J. Immunol., 25, 137-146, 1995.
9. Zitvogel, L., Tahara, H., Robbins, P. D., Storkus, W. J., Clarke, M. R., Nalesnik, M. A., and Lotze, M. T. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J. Immunol., 155: 1393-1403, 1995.
10. Tahara, H., Zitvogel, L., Storkus, W. J., Elder, E. M., Kinzler, D., Whiteside, T. L., Robbins, P., and Lotze, M. T. Antitumor effects in patients with melanoma, head and neck and breast cancer in a Phase I/II clinical trial of interleukin-12 (IL-12). Proc. Am. Soc. Clin. Oncol., 16: 439a, 1997.
11. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N., and Schuler, G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-11 production by T helper 1 cells. Eur. J. Immunol., 26: 659-668, 1996.
12. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N., and Schuler, G. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med., 184: 741-746, 1996.
13. Bhardwaj, N., Seder, R. A., Reddy, A., and Feldman, M. V. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J. Clin. Investig., 98: 715-722, 1996.
14. Macatonia, S. E., Taylor, P. M., Knight, S. C., and Askonas, B. A. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med., 169: 1255-1264, 1989.
15. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Kast, W. M., Deleo, A. B., and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat. Med., 1: 1297-1302, 1995.
16. Porgador, A., and Gilboa, E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med., 182: 255-260, 1995.
17. Porgador, A., Snyder, D., and Gilboa, E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol., 156: 2918-2926, 1996.
18. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., Deleo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97, 1996.
19. Flamand, V., Somasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., and Moser, M. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol., 24: 605-610, 1994.
20. Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D., and Gilboa, E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med., 186: 1177-1182, 1997.
21. Boczkowski, D., Nair, S. K., Synder, D., and Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med., 184: 465-472, 1996.
22. Zitvogel, L., Robbins, P. D., Storkus, W. J., Clarke, M. R., Maeurer, M. J., Campbell, R. L., Davis, C. G., Tahara, H., Schreiber, R. D., and Lotze, M. T. Interleukin-12 and B7 1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol., 26: 1335-1341, 1996.
23. Cormack, B. P., Valdivia, R. H., and Falkow, S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene (Amst.), 173: 33-38, 1996.
24. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176: 1693-1702, 1992.
25. Kolani, H., Newton, P. B., III, Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., and McGarrity, G. J. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther, 5: 19-28, 1994.
26. Bahnson, A. B., Dunigan, J. T., Baysal, B. E., Mohney, T., Atchison, R. W., Nimgaonkar, M. T., Ball, E. D., and Barranger, J. A. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods, 54: 131-143, 1995.
27. Horan, P. K., Melnicoff, M. J., Jensen, B. D., and Slezak, S. E. Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol., 33: 469-490, 1990.
28. Slezak, S. E., and Horan, P. K. Fluorescent in vivo tracking of hematopoietic cells. Part I: technical considerations. Blood, 74: 2171-2177, 1989.
29. Henderson, R. A., Nimgaonkar, M. T., Watkins, S. C., Robbins, P. D., Ball, E. D., and Finn, O. J. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res., 56: 3763-3770, 1996.
30. Reeves, M. E., Royal, R. E., Lam, J. S., Rosenberg, S. A., and Hwu, P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res., 56: 5672-5677, 1996.
31. Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., and Hwu, P. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med., 186: 1213-1221, 1997.
32. Smith, C. A., Woodruff, L. S., Kitchingman, G. R., and Rooney, C. M. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J. Virol., 70: 6733-6740, 1996.
33. Grohmann, U., Belladonna, M. L., Bianchi, R., Orabona, C., Ayroldi, E., Fioretti, M. C., and Puccetti, P. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity, 9: 315-323, 1998.
34. Gong, J., Chen, D., Kashiwaba, M., and Kufe, D. Irduction of antitumor activity immunization with fusions of dendritic and carcinoma cells. Nat. Med., 3: 558-561, 1997.
35. Pierre, P., Turley, S. J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinman, R. M., and Mellman, I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (Lond.), 388: 787-792, 1997.
36. Inaba, K., Inaba, M., Naito, M., and Steinman, R. M. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med., 178: 479-488, 1993.
37. Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature (Lond.), 388: 782-787, 1997.
38. Tannenbaum, C. S., Wicker, N., Armstrong, D., Tubbs, R., Finke, J., Bukowski, R., and Hamilton, T. A. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol., 156: 693-699, 1996.
39. Camps, J. L., Chang, S. M., Hsu, T. C., Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C., and Chung, L. W. K. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 87: 75-79, 1990.
40. Comil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., and Kerbel, R. S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA, 88: 6028-6032, 1991.